Industry

VitalConnect Announces Investment from HCA Healthcare to Accelerate Commercial Growth and Create Strategic Partnership

Strategic Investment Expected to Help Accelerate Cardiac Monitoring and Strategic Relationship Aims to Create Improved Disease State Treatment Models SAN JOSE, Calif.–(BUSINESS WIRE)–#vitalconnect–VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced the completion of an investment funded by Health Insight Capital, the investment arm of HCA Healthcare Inc., (NYSE: HCA), one … [Read more…]

Aicardi Goutieres Syndrome Epidemiology Forecasts Report 2019-2032: Focus on 7MM – United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Aicardi Goutieres Syndrome – Epidemiology Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This ‘Aicardi-Goutieres Syndrome (AGS) – Epidemiology Forecast – 2032’ report delivers an in-depth understanding of the historical and forecasted epidemiology of Aicardi-Goutieres Syndrome (AGS) in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and … [Read more…]

Ventricular Tachycardia (V-tach or VT) Drug Pipeline Insight Report 2022 Featuring Espero BioPharma, CTP amio Vivasc Therapeutics, Aladorian – ARMGO Pharma, & RyR2 Research Program – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Ventricular Tachycardia (V-tach or VT) – Pipeline Insight, 2022” drug pipelines has been added to ResearchAndMarkets.com’s offering. This Ventricular Tachycardia (V-tach or VT) – Pipeline Insight, 2022″ report provides comprehensive insights about 5+ companies and 7+ pipeline drugs in Ventricular Tachycardia (V-tach or VT) pipeline landscape. It covers the pipeline drug profiles, including … [Read more…]

Generalized Myasthenia Gravis (gMG) Epidemiology Forecasts Report 2019-2032: Focus on 7MM – United States, Germany, Spain, Italy, France, United Kingdom, and Japan – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Generalized Myasthenia Gravis (gMG) – Epidemiology Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This ‘Generalized Myasthenia Gravis (gMG)- Epidemiology Forecast – 2032’ report delivers an in-depth understanding of Generalized Myasthenia Gravis (gMG) historical and forecasted epidemiology in the United States, EU-5 (Germany, Spain, Italy, France, and the United Kingdom), and … [Read more…]

Regencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial

– The Sik-Kee Au TCM Brain Theory® Assessment for ADHD and ASD (“SKATBT-A3”), which measures the effectiveness of the treatment on the patient’s overall body and neurodevelopmental conditions, showed a mean percentage improvement of 37% in the second efficacy trial based on the scoring system of SKATBT-A3. – The first efficacy trial using personalized TCM … [Read more…]

New Research from the Clarify Health Institute Highlights the Severity of Pediatric Mental Health Conditions in the United States

SAN FRANCISCO–(BUSINESS WIRE)–Clarify Health, a leading cloud analytics and value-based payments platform company, today announced the publication of new research on pediatric mental health in a brief titled, “The Kids Are Not Alright: Pediatric Mental Health Care Utilization from 2016 – 2021.” The research was conducted by the Clarify Health Institute, which is led by … [Read more…]

Virtis Health Expands Ohio Presence With Opening of Ambulatory Infusion Centers in Columbus and Cleveland

Clinical Expertise and Advanced Therapies Cater to Growing Patient Population Statewide COLUMBUS, Ohio & CLEVELAND–(BUSINESS WIRE)–#VirtisHealthAmbulatoryInfusionCenters—Virtis Health, an innovative, national provider dedicated to therapeutic and diagnostic services for patients with complex conditions requiring specialty infusible and injectable medications, announced today the unveiling of ambulatory infusion centers (AIC) in Columbus and Cleveland, Ohio. Virtis Health is … [Read more…]

Amylyx Pharmaceuticals Announces Publication of Preclinical Data Showing Potential Synergistic Effect of AMX0035 Compared to Individual Compounds

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced the publication of preclinical data showing the effect of sodium phenylbutyrate (PB) and taurursodiol (TURSO, also known as ursodoxicoltaurine) on the transcriptomic and metabolomic profiles of primary skin fibroblasts from adults with sporadic amyotrophic lateral sclerosis (ALS) and adults without ALS. These … [Read more…]

Sickle Cell Warrior Program from NMDP/Be The Match Helps Eliminate Barriers to Equitable Care

The free program helps individuals become more care-prepared through information, resources, connections, counseling and support. MINNEAPOLIS–(BUSINESS WIRE)–As part of Sickle Cell Disease (SCD) Awareness Month in September, The National Marrow Donor Program® (NMDP)/Be The Match® is sharing the Sickle Cell Warrior Program, an initiative designed to eliminate barriers to equitable care, facilitate early referral and … [Read more…]

CEL-SCI’S Phase 3 Data Presented at ESMO 2022: Neoadjuvant Multikine Achieved Groundbreaking Tumor Response & Extended Overall Survival in Locally Advanced Head and Neck Cancer

Poster presentations by Dr. Philip Lavin, a biostatistician for 80 FDA approvals/clearances, and Dr. József Tímár, Professor and Director of the Central Pathology Laboratory at Semmelweis University View the posters here: LINK VIENNA, Va.–(BUSINESS WIRE)–$CVM #ESMO22–CEL-SCI Corporation (NYSE American: CVM) today announced two poster presentations were delivered at the European Society for Medical Oncology (EMSO) … [Read more…]